1. Home
  2. BIAF vs MMA Comparison

BIAF vs MMA Comparison

Compare BIAF & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIAF
  • MMA
  • Stock Information
  • Founded
  • BIAF 2014
  • MMA 2013
  • Country
  • BIAF United States
  • MMA Australia
  • Employees
  • BIAF N/A
  • MMA N/A
  • Industry
  • BIAF Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MMA
  • Sector
  • BIAF Health Care
  • MMA
  • Exchange
  • BIAF Nasdaq
  • MMA Nasdaq
  • Market Cap
  • BIAF 21.4M
  • MMA 18.8M
  • IPO Year
  • BIAF 2022
  • MMA 2024
  • Fundamental
  • Price
  • BIAF $1.24
  • MMA $1.81
  • Analyst Decision
  • BIAF Strong Buy
  • MMA
  • Analyst Count
  • BIAF 1
  • MMA 0
  • Target Price
  • BIAF $6.00
  • MMA N/A
  • AVG Volume (30 Days)
  • BIAF 102.5K
  • MMA 82.0K
  • Earning Date
  • BIAF 11-14-2024
  • MMA 12-03-2024
  • Dividend Yield
  • BIAF N/A
  • MMA N/A
  • EPS Growth
  • BIAF N/A
  • MMA N/A
  • EPS
  • BIAF N/A
  • MMA N/A
  • Revenue
  • BIAF $9,367,785.00
  • MMA $375,175.00
  • Revenue This Year
  • BIAF $302.41
  • MMA N/A
  • Revenue Next Year
  • BIAF $15.00
  • MMA N/A
  • P/E Ratio
  • BIAF N/A
  • MMA N/A
  • Revenue Growth
  • BIAF 2813.87
  • MMA 45.19
  • 52 Week Low
  • BIAF $1.20
  • MMA $1.41
  • 52 Week High
  • BIAF $3.62
  • MMA $5.25
  • Technical
  • Relative Strength Index (RSI)
  • BIAF 36.67
  • MMA N/A
  • Support Level
  • BIAF $1.21
  • MMA N/A
  • Resistance Level
  • BIAF $1.37
  • MMA N/A
  • Average True Range (ATR)
  • BIAF 0.08
  • MMA 0.00
  • MACD
  • BIAF 0.01
  • MMA 0.00
  • Stochastic Oscillator
  • BIAF 17.50
  • MMA 0.00

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

About MMA Alta Global Group Limited

Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.

Share on Social Networks: